Eagle Pharmaceuticals logo
Eagle Pharmaceuticals EGRX
$ 2.14 -39.89%

Quarterly report 2023-Q2
added 08-08-2023

report update icon

Eagle Pharmaceuticals Cost of Revenue 2011-2024 | EGRX

Annual Cost of Revenue Eagle Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
85.5 M 31.5 M 33.6 M 47.9 M 42.4 M 33.7 M 35.8 M 15.6 M 11.7 M 7.38 M 3.17 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
85.5 M 3.17 M 31.7 M

Quarterly Cost of Revenue Eagle Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
16.9 M 17.3 M - 20.9 M 21.2 M 25.2 M - 5.49 M 7.91 M 8.44 M - 8.73 M 10.3 M 4.76 M - 12.1 M 18.2 M 9.55 M - 8.62 M 14.1 M 7.22 M - 4.82 M 8.91 M - - 10.4 M 11.5 M 14.6 M - 3.75 M 3.35 M 5.95 M 1.78 M 2.18 M 1.56 M 3.36 M 2.67 M 4.45 M 2.93 M 1.31 M - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
25.2 M 1.31 M 9.1 M